[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (2,650)

Search Parameters:
Keywords = electrophoresis

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
20 pages, 3992 KiB  
Article
Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells
by Ilham H. Kadhim, Adeolu S. Oluremi, Bijay P. Chhetri, Anindya Ghosh and Nawab Ali
Bioengineering 2024, 11(9), 931; https://doi.org/10.3390/bioengineering11090931 (registering DOI) - 17 Sep 2024
Abstract
Inositol hexakisphosphate (InsP6) is the most abundant inositol polyphosphate both in plant and animal cells. Exogenous InsP6 is known to inhibit cell proliferation and induce apoptosis in cancerous cells. However, cellular entry of exogenous InsP6 is hindered due to [...] Read more.
Inositol hexakisphosphate (InsP6) is the most abundant inositol polyphosphate both in plant and animal cells. Exogenous InsP6 is known to inhibit cell proliferation and induce apoptosis in cancerous cells. However, cellular entry of exogenous InsP6 is hindered due to the presence of highly negative charge on this molecule. Therefore, to enhance the cellular delivery of InsP6 in cancerous cells, InsP6 was encapsulated by chitosan (CS), a natural polysaccharide, via the ionic gelation method. Our hypothesis is that encapsulated InsP6 will enter the cell more efficiently to trigger its apoptotic effects. The incorporation of InsP6 into CS was optimized by varying the ratios of the two and confirmed by InsP6 analysis via polyacrylamide gel electrophoresis (PAGE) and atomic absorption spectrophotometry (AAS). The complex was further characterized by Scanning Electron Microscopy (SEM) and Fourier Transform Infrared Spectroscopy (FTIR) for physicochemical changes. The data indicated morphological changes and changes in the spectral properties of the complex upon encapsulation. The encapsulated InsP6 enters human breast cancer MCF-7 cells more efficiently than free InsP6 and triggers apoptosis via a mechanism involving the production of reactive oxygen species (ROS). This work has potential for developing cancer therapeutic applications utilizing natural compounds that are likely to overcome the severe toxic effects associated with synthetic chemotherapeutic drugs. Full article
(This article belongs to the Special Issue Advances in Hydrogels for Tissue Engineering Applications)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Schematic depiction of the concept of cellular entry of exogenously administered InsP<sub>6</sub> after encapsulation with chitosan by ionic gelation to shield off the negative charge. Note that the encapsulated InsP<sub>6</sub> enters the cell through cell membrane, whereas negatively charged free InsP<sub>6</sub> is unable to enter the cell membrane.</p>
Full article ">Figure 2
<p>Schematic illustration of the preparation of the CS:InsP<sub>6</sub> nanomaterial complex by ionic gelation. Chitosan dissolved in acetic acid (5.0 mg/mL) and InsP<sub>6</sub> dissolved in deionized water (5.0 mg/mL) were mixed in varying proportions and stirred for 30 min followed by pH adjustment. The CS:InsP<sub>6</sub> complex was purified by centrifugation and washing with ethanol and lyophilized to dry powder.</p>
Full article ">Figure 3
<p>Detection of InsP<sub>6</sub> contents in the CS:InsP<sub>6</sub> complex by PAGE. Optimization of InsP<sub>6</sub> incorporation in chitosan was carried out by varying the ratios of CS:InsP<sub>6</sub> (<b>B</b>). Standard InsP<sub>6</sub> with known concentrations were also run in parallel to establish the linearity of detection (<b>A</b>). Band densities were analyzed by image J software. (<b>B</b>) shows the amounts of InsP<sub>6</sub> detected in the samples with various ratios of CS:InsP<sub>6</sub> applied on the gel. The maximum amount of InsP<sub>6</sub> (0.49 μg) was detected in the sample with a CS:InsP<sub>6</sub> ratio of 2.5:1.0. This amount (0.49 μg), when calculated using the dilution factor of the samples loaded on the gel, provides a total incorporation of 49 ug InsP<sub>6</sub> per mg CS. Data shown are a representative of at least three independent experiments with similar results. The error bars are not shown as the data shown are from a single experiment repeated at least three times.</p>
Full article ">Figure 4
<p>SEM images of CS (<b>A</b>) and the CS:InsP<sub>6</sub> complex (<b>B</b>). Arrows point to the empty spaces in CS (<b>A</b>) that were perhaps filled by InsP<sub>6</sub> (<b>B</b>), showing morphological changes following encapsulation. The CS:InsP<sub>6</sub> complex at a ratio of 2.5:1.0 was used for SEM analysis in (<b>B</b>). Electron micrographs shown are representative images seen in replicate experiments with similar results.</p>
Full article ">Figure 5
<p>FTIR spectra of (<b>a</b>) InsP<sub>6</sub>, (<b>b</b>) CS, and (<b>c</b>) encapsulated complex with a CS:InsP<sub>6</sub> ratio of 2.5:1.0. Note that the spectral properties of the characteristic bands at specific wavenumbers in InsP<sub>6</sub> (<b>a</b>) and CS (<b>b</b>) are changed upon encapsulation (<b>c</b>).</p>
Full article ">Figure 6
<p>Cellular uptake of encapsulated InsP<sub>6</sub>. Band intensity was analyzed by image J software. (<b>A</b>) shows quantitative detection of InsP<sub>6</sub> in the CS:IsP<sub>6</sub> complex with a CS:InsP<sub>6</sub> ratio of 2.5:1.0. A volume of 5, 10, and 20 µL of the complex loaded on the gel gave 0.15, 0.36, and 0.64 µg InsP<sub>6</sub>, respectively, showing a concentration-dependent linear increase in the detection of InsP<sub>6</sub> in the complex. (<b>B</b>) shows a significant increase in InsP<sub>6</sub> uptake by MCF-7 cells using the encapsulated complex with a CS:InsP<sub>6</sub> ratio of 2.5:1.0 as compared to corresponding free InsP<sub>6</sub> and CS. Data shown are representative of experiments performed independently at least three times with similar results. Statistical analysis is not shown as the data are from a representative experiment.</p>
Full article ">Figure 7
<p>Dose- and time-dependent induction of cell viability in MCF-7 cells by encapsulated InsP<sub>6</sub> treatment. Cell viability was determined at 24 h (<b>A</b>), 48 h (<b>B</b>), and 72 h (<b>C</b>) by MTT assay using the given doses of free InsP<sub>6</sub> (1.0–4.0 µM) and equivalent amounts of the CS: InsP<sub>6</sub> complex that would give similar doses of free InsP<sub>6</sub>. Data are shown as means ± SD from three independent experiments. All experimental values were statistically compared with their respective controls to determine any significant differences. Only treatment with 4 µM encapsulated InsP<sub>6</sub> gave a significant difference as compared with 4 µM free InsP<sub>6</sub>. * <span class="html-italic">p</span> value ≤ 0.001 or ** <span class="html-italic">p</span> ≤ 0.0001 show significantly different values as compared to the respective controls.</p>
Full article ">Figure 8
<p>Effect of encapsulated InsP<sub>6</sub> on apoptosis. MCF-7 cells were incubated with 4 µM of encapsulated InsP<sub>6</sub> for 72 h to induce apoptosis. Etoposide (100 µM) was used as a positive control. (<b>A</b>) MCF-7 cells were stained with acridine orange/ethidium bromide and visualized under UV light using a fluorescent microscope. (<b>B</b>) The percentage of apoptosis was determined by counting 200–300 live (green) and/or dead (red) cells. Values shown are mean ±SD from three experiments, each performed in triplicate. ** <span class="html-italic">p</span> value ≤ 0.001 as compared to the control.</p>
Full article ">Figure 9
<p>Effect of encapsulated InsP<sub>6</sub> on ROS generation. MCF-7 cells were treated with 4 µM free InsP<sub>6</sub> equivalent of the encapsulated CS:InsP<sub>6</sub> complex for 72 h in a 96-well microplate. Etoposide (100 µM) was used as a positive control. Cells were then stained with 10 µM DCFH-DA and fluorescence intensity was recorded using a fluorescence microplate reader. Values shown are mean ± SD from three independent experiments, each performed in triplicate. * <span class="html-italic">p</span> value of ≤0.0001 was considered significantly different compared to the control.</p>
Full article ">Figure 10
<p>Determination of specificity of encapsulated InsP<sub>6</sub>-induced apoptosis by flow cytometry (<b>A</b>). Apoptosis was measured by using a commercially available Vybrant apoptosis assay kit #4. Live cells - are shown as green in lower left quadrant and apoptotic cells are shown as blue in <b>lower and upper right</b> quadrant. Necrotic cells give a red color which are expected to show up in upper left quadrant. The data shown are representative of an experiment repeated at least three times with similar results. (<b>B</b>) shows statistical analysis results of the flow cytometry data showing mean ± standard deviation (SD) from three independent experiments. The % apoptosis values were obtained by combining early and late apoptosis values from the lower and upper right quadrants, respectively. One-way ANOVA with multiple comparisons was used to determine values that were statistically significant. **** <span class="html-italic">p</span> &lt; 0.0001 was considered statistically significant values compared with their respective controls.</p>
Full article ">
10 pages, 11741 KiB  
Article
mRNA Fragmentation Pattern Detected by SHAPE
by Shanshan Feng, Ting Chen, Yunlong Zhang and Changrui Lu
Curr. Issues Mol. Biol. 2024, 46(9), 10249-10258; https://doi.org/10.3390/cimb46090610 (registering DOI) - 16 Sep 2024
Viewed by 139
Abstract
The success of messenger RNA (mRNA) vaccines in controlling COVID-19 has warranted further developments in new technology. Currently, their quality control process largely relies on low-resolution electrophoresis for detecting chain breaks. Here, we present an approach using multi-primer reverse transcription sequencing (MPRT-seq) to [...] Read more.
The success of messenger RNA (mRNA) vaccines in controlling COVID-19 has warranted further developments in new technology. Currently, their quality control process largely relies on low-resolution electrophoresis for detecting chain breaks. Here, we present an approach using multi-primer reverse transcription sequencing (MPRT-seq) to identify degradation fragments in mRNA products. Using this in-house-made mRNA containing two antigens and untranslated regions (UTRs), we analyzed the mRNA completeness and degradation pattern at a nucleotide resolution. We then analyzed the sensitive base sequence and its correlation with the secondary structure. Our MPRT-seq mapping shows that certain sequences on the 5′ of bulge–stem–loop structures can result in preferential chain breaks. Our results agree with commonly used capillary electrophoresis (CE) integrity analysis but at a much higher resolution, and can improve mRNA stability by providing information to remove sensitive structures or sequences in the mRNA sequence design. Full article
(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Schematic of green fluorescent protein–luciferase (GFP-Luc) mRNA and six reverse-transcription (RT) primer positions. The 5′ untranslated region (UTR) (residues 1–52), Kozak sequence (residues 47–52) at the 3′ end of 5′ UTR, Luc (residues 53–1702), linker (residues 1703–1768), GFP (residues 1769–2485), stop codons (residues 2486–2491), 3′ UTR (residues 2492–2786) and poly (<b>A</b>) (residues 2787–2896) are shown in purple, blue, pink, green, black, orange and grey, respectively. The black arrow and the yellow eight-pointed star represent the reverse-transcription DNA primer and 5′-FAM label; (<b>B</b>) mRNA degradation study workflow.</p>
Full article ">Figure 2
<p>Capillary electrophoresis (CE) evaluation of GFP-Luc mRNA integrity under accelerated degradation. mRNA samples were analyzed using the Qsep CE analyzer. (<b>A</b>) Electropherograms of mRNA under accelerated degradation. The freeze–thaw cycles were 5, 10 and 20, respectively; incubation was performed at 37 °C for 24 h and 48 h, respectively. The alignment marker is RNA-LM (20 nt), and dashed lines indicate the cutoff of the main mRNA fragments peak, which ranges from approximately 2100 to 3300 nt. (<b>B</b>) mRNA integrity derived from CE analysis: the left panel shows the degradation effect of freeze–thaw cycles, with CE integrity bars for 5, 10 and 20 freeze–thaw cycles shown in red, green and blue, respectively. The right panel shows the degradation effect of 37 °C incubation, with CE integrity bars for 24 h and 48 h incubations shown in orange and cyan, respectively. The CE integrity bar for the control is shown in black.</p>
Full article ">Figure 3
<p>Multi-primer reverse transcription sequencing (MPRT-seq) reveals GFP-Luc mRNA reactivity changes under accelerated degradation. (<b>A</b>,<b>B</b>) left panels show MPRT-seq reactivity changes under freeze–thaw cycles and 37 °C heating incubation, respectively. mRNA length is plotted on the <span class="html-italic">X</span>-axis. The right panels show the mean reactivity of MPRT-seq under degradation acceleration treatment. The coloring of the MPRT-seq mean reactivity bars are consistent with <a href="#cimb-46-00610-f002" class="html-fig">Figure 2</a>.</p>
Full article ">Figure 4
<p>GFP-Luc mRNA secondary structure prediction and evaluation of high-degradation-reactivity sequences. (<b>A</b>) Secondary structure prediction was performed using RNAfold web server with the sequence from residue 1 to 2789, except the poly (<b>A</b>) tail. The coloring of GFP-Luc mRNA elements is consistent with <a href="#cimb-46-00610-f001" class="html-fig">Figure 1</a>A schematic. Additionally, 1–4 represent sequences that are sensitive to both freeze–thaw cycles and 37 °C heating incubation, and their corresponding positions are shown in the secondary structure. (<b>B</b>–<b>E</b>) left panels represent MPRT-seq reactivity under degradation acceleration, with consistent secondary structure motifs shown on right side. The dotted line shows the relative mean reactivity derived from Equation (1). The red circles in the secondary structure motifs represent relative high-degradation nucleotide positions, and black circles represent relatively low activities.</p>
Full article ">
16 pages, 2820 KiB  
Article
Olea europaea L. Leaves as a Source of Anti-Glycation Compounds
by Marzia Vasarri, Maria Camilla Bergonzi, Emilija Ivanova Stojcheva, Anna Rita Bilia and Donatella Degl’Innocenti
Molecules 2024, 29(18), 4368; https://doi.org/10.3390/molecules29184368 - 14 Sep 2024
Viewed by 161
Abstract
High concentrations of advanced glycation end products (AGEs) have been linked to diseases, including diabetic complications. The pathophysiological effects of AGEs are mainly due to oxidative stress and inflammatory processes. Among the proteins most affected by glycation are albumin, the most abundant circulating [...] Read more.
High concentrations of advanced glycation end products (AGEs) have been linked to diseases, including diabetic complications. The pathophysiological effects of AGEs are mainly due to oxidative stress and inflammatory processes. Among the proteins most affected by glycation are albumin, the most abundant circulating protein, and collagen, which has a long biological half-life and is abundant in the extracellular matrix. The potential cellular damage caused by AGEs underscores the importance of identifying and developing natural AGE inhibitors. Indeed, despite initial promise, many synthetic inhibitors have been withdrawn from clinical trials due to issues such as cytotoxicity and poor pharmacokinetics. In contrast, natural products have shown significant potential in inhibiting AGE formation. Olea europaea L. leaves, rich in bioactive compounds like oleuropein and triterpenoids, have attracted scientific interest, emphasizing the potential of olive leaf extracts in health applications. This study investigates the anti-glycation properties of two polyphenol-rich extracts (OPA40 and OPA70) and a triterpene-enriched extract (TTP70) from olive leaves. Using in vitro protein glycation methods with bovine serum albumin (BSA)–glucose and gelatin–glucose systems, this study assesses AGE formation inhibition by these extracts through native polyacrylamide gel electrophoresis (N-PAGE) and autofluorescence detection. OPA40 and OPA70 exhibited strong, dose-dependent anti-glycation effects. These effects were corroborated by electrophoresis and further supported by similar results in a gelatin–glucose system. Additionally, TTP70 showed moderate anti-glycation activity, with a synergistic effect of its components. The results support the real possibility of using olive leaf bioproducts in ameliorating diabetic complications, contributing to sustainable bio-economy practices. Full article
Show Figures

Figure 1

Figure 1
<p>In vitro glycation of albumin and the inhibitory effect of OPA40 and OPA70 on A-AGE formation. Relative fluorescence intensity (λex/λem 335/385 nm) of unglycated albumin (BSA), A-AGE, and A-AGE with OPA40 (0.5–2.5 mg/mL), OPA70 (0.5–2.5 mg/mL), or AG (10 mM) obtained at 60 °C for 72 h. All values are reported as percentage ratio with respect to unglycated BSA. Data are the mean of three independent experiments. Error bars represent standard deviation. Tukey’s test: *** <span class="html-italic">p</span> &lt; 0.001 vs. unglycated BSA; °°° <span class="html-italic">p</span> &lt; 0.001 vs. A-AGE formed in the absence of the extracts.</p>
Full article ">Figure 2
<p>Representative N-PAGE image of unglycated albumin (BSA) and A-AGE obtained at 60 °C for 72 h in the absence or presence of OPA40 and OPA70 extracts. A-AGE obtained in the presence of AG was used as a protein glycation inhibition control. The symbols (+) and (−) represent the anode and cathode in the N-PAGE gel, respectively.</p>
Full article ">Figure 3
<p>Time-dependent formation of G-AGE. The relative fluorescence intensity of G-AGE was measured from time 0 to 96 h at 335 and 385 nm excitation and emission wavelength. Values are reported as percentages compared to the fluorescence intensity of gelatin at time 0. Values are the mean ± standard deviation of three experiments.</p>
Full article ">Figure 4
<p>In vitro glycation of gelatin and the inhibitory effect of the OPA40 and OPA70 on G-AGE formation. Relative fluorescence intensity (λ<sub>ex</sub>/λ<sub>em</sub> 335/385 nm) of unglycated gelatin, G-AGE, and G-AGE with OPA40 (0.5–2.5 mg/mL), OPA70 (0.5–2.5 mg/mL), or AG (10 mM) obtained at 45 °C for 72 h. All values are reported as percentage ratio with respect to unglycated gelatin. Data are the mean of three independent experiments. Error bars represent standard deviation. Tukey’s test: *** <span class="html-italic">p</span> &lt; 0.001 vs. unglycated gelatin; °°° <span class="html-italic">p</span> &lt; 0.001 vs. G-AGE formed in the absence of the extracts.</p>
Full article ">Figure 5
<p>In vitro glycation of albumin and the inhibitory effect of TTP70 and OA on A-AGE formation. (<b>A</b>) Relative fluorescence intensity (λ<sub>ex</sub>/λ<sub>em</sub> 335/385 nm) of unglycated albumin (BSA), A-AGE, and A-AGE obtained in the presence of OA (0.15 and 0.2 mg/mL), TTP70 (0.3 and 0.4 mg/mL), or AG (10 mM) at 60 °C for 72 h. All values are reported as percentage ratio to unglycated albumin (BSA). Data are the mean of three independent experiments. Error bars represent standard deviation. Tukey’s test: *** <span class="html-italic">p</span> &lt; 0.001 vs. unglycated BSA; °° <span class="html-italic">p</span> &lt; 0.01, °°° <span class="html-italic">p</span> &lt; 0.001 vs. A-AGE formed in the absence of OA or TTP70. (<b>B</b>) Representative N-PAGE image of unglycated BSA and A-AGE obtained at 60 °C for 72 h in the presence or absence of OA and TTP70 extracts. A-AGE obtained in the presence of AG was used as a control for protein glycation inhibition. The symbols (+) and (−) represent the anode and cathode in the N-PAGE gel, respectively.</p>
Full article ">Figure 6
<p>In vitro glycation of gelatin and the inhibitory effect of the TTP70 and OA on G-AGE formation. Relative fluorescence intensity (λ<sub>ex</sub>/λ<sub>em</sub> 335/385 nm) of unglycated gelatin, G-AGE, and G-AGE with OA (0.15–0.2 mg/mL), TTP70 (0.3–0.4 mg/mL), or AG (10 mM) obtained at 45 °C for 72 h. All values are reported as percentage ratio with respect to unglycated gelatin. Data are the mean of three independent experiments. Error bars represent standard deviation. Tukey’s test: *** <span class="html-italic">p</span> &lt; 0.001 vs. unglycated gelatin; °°° <span class="html-italic">p</span> &lt; 0.001 vs. G-AGE formed in the absence of the extracts.</p>
Full article ">Scheme 1
<p>(<b>a</b>) In vitro AGE formation by albumin–glucose system (A-AGE), in the presence of (<b>b</b>) <span class="html-italic">Olea europea</span> L. leaf extracts or (<b>c</b>) aminoguanidine (AG). The image of the BSA was taken from the following website: <a href="https://www.chemicalbook.com/Article/Classification-of-bovine-serum-albumin.htm" target="_blank">https://www.chemicalbook.com/Article/Classification-of-bovine-serum-albumin.htm</a>, accessed on 17 July 2024.</p>
Full article ">Scheme 2
<p>(<b>a</b>) In vitro AGE formation by gelatin–glucose system (G-AGE), in the presence of (<b>b</b>) <span class="html-italic">Olea europea</span> L. leaf extracts or (<b>c</b>) aminoguanidine (AG).</p>
Full article ">
23 pages, 4268 KiB  
Article
In Vitro Wound-Healing Potential of Phenolic and Polysaccharide Extracts of Aloe vera Gel
by Andreea Iosageanu, Elena Mihai, Ana-Maria Seciu-Grama, Elena Utoiu, Alexandra Gaspar-Pintiliescu, Florentina Gatea, Anisoara Cimpean and Oana Craciunescu
J. Funct. Biomater. 2024, 15(9), 266; https://doi.org/10.3390/jfb15090266 - 13 Sep 2024
Viewed by 302
Abstract
The present study aimed to conduct a comparative investigation of the biological properties of phenolic and polysaccharide extracts obtained using an ultrasound-assisted technique from Aloe vera gel and their effects on each stage of the wound healing process in in vitro experimental models. [...] Read more.
The present study aimed to conduct a comparative investigation of the biological properties of phenolic and polysaccharide extracts obtained using an ultrasound-assisted technique from Aloe vera gel and their effects on each stage of the wound healing process in in vitro experimental models. HPLC analysis showed that the phenolic extract contained aloin, ferulic, and caffeic acid, as well as quercetin dihydrate, as major compounds. Capillary zone electrophoresis indicated the prevalence of mannose and glucose in the polysaccharide extract. Cell culture testing revealed the anti-inflammatory properties of the phenolic extract at a concentration of 0.25 mg/mL through significant inhibition of pro-inflammatory cytokines—up to 28% TNF-α and 11% IL-8 secretion—in inflamed THP-1-derived macrophages, while a pro-inflammatory effect was observed at 0.5 mg/mL. The phenolic extract induced 18% stimulation of L929 fibroblast proliferation at a concentration of 0.5 mg/mL, enhanced the cell migration rate by 20%, and increased collagen type I synthesis by 18%. Moreover, the phenolic extract exhibited superior antioxidant properties by scavenging free DPPH (IC50 of 2.50 mg/mL) and ABTS (16.47 mM TE/g) radicals, and 46% inhibition of intracellular reactive oxygen species (ROS) production was achieved. The polysaccharide extract demonstrated a greater increase in collagen synthesis up to 25%, as well as antibacterial activity against Staphylococcus aureus with a bacteriostatic effect at 25 mg/mL and a bactericidal one at 50 mg/mL. All these findings indicate that the phenolic extract might be more beneficial in formulations intended for the initial phases of wound healing, such as inflammation and proliferation, while the polysaccharide extract could be more suitable for use during the remodeling stage. Moreover, they might be combined with other biomaterials, acting as efficient dressings with anti-inflammatory, antioxidant, and antibacterial properties for rapid recovery of chronic wounds. Full article
(This article belongs to the Special Issue Biomaterials for Wound Healing and Tissue Repair)
Show Figures

Figure 1

Figure 1
<p>Scheme of the preparation of phenolic and polysaccharide extracts from <span class="html-italic">Aloe vera</span> gel using UAE.</p>
Full article ">Figure 2
<p>Quantification of TNF-α (<b>a</b>) and IL-8 (<b>b</b>) levels in LPS-stimulated THP-1-derived macrophages (light grey) and after treatment with phenolic and polysaccharide extract of <span class="html-italic">Aloe vera</span> gel. Untreated cells served as the control group (dark grey). * <span class="html-italic">p</span> &lt; 0.05, # <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Viability of L929 fibroblasts at 24 (<b>a</b>) and 48 (<b>b</b>) h of treatment with phenolic and polysaccharide UAE extracts of <span class="html-italic">Aloe vera</span> gel, determined by Neutral Red assay. * <span class="html-italic">p</span> &lt; 0.05, # <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 4
<p>Phase contrast images showing the cell morphology of L929 fibroblasts at 48 h of treatment with phenolic and polysaccharide UAE extracts of <span class="html-italic">Aloe vera</span> gel. Scale bar = 50 μm.</p>
Full article ">Figure 5
<p>(<b>a</b>) Phase contrast images showing cell migration of L929 cells treated with phenolic and polysaccharide UAE extracts of <span class="html-italic">Aloe vera</span> gel for 24 h in a scratch model assay. Scale bar = 100 µm; (<b>b</b>) cell migration rate determined by ImageJ analysis. * <span class="html-italic">p</span> &lt; 0.05, # <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 6
<p>Collagen type I production in L929 fibroblasts after 72 h of treatment with phenolic and polysaccharide UAE extracts of <span class="html-italic">Aloe vera</span> gel, as determined by ELISA. * <span class="html-italic">p</span> &lt; 0.05, # <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 7
<p>(<b>a</b>) Flow cytometry histograms showing count vs. fluorescence intensity in L929 fibroblasts after 48 h of treatment with phenolic and polysaccharide UAE extracts of <span class="html-italic">Aloe vera</span> gel (red—t-BHP treated cells, green—ascorbic acid treated cells, purple - aloe extracts treated cells). (<b>b</b>) Percentage of intracellular ROS production. * <span class="html-italic">p</span> &lt; 0.05, # <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 8
<p>Bacterial growth of <span class="html-italic">S. aureus</span> (<b>a</b>) and <span class="html-italic">P. aeruginosa</span> (<b>b</b>) in the presence of the phenolic and polysaccharide UAE extracts of <span class="html-italic">Aloe vera</span> gel. * <span class="html-italic">p</span> &lt; 0.05, # <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">
10 pages, 433 KiB  
Article
Association of VDR Polymorphisms with Muscle Mass Development in Elite Young Soccer Players: A Pilot Study
by Laura Flore, Renato Robledo, Laura Dettori, Marco Scorcu, Paolo Francalacci, Filippo Tocco, Myosotis Massidda and Carla Maria Calò
Sports 2024, 12(9), 253; https://doi.org/10.3390/sports12090253 - 13 Sep 2024
Viewed by 197
Abstract
The vitamin D receptor (VDR) is an important candidate gene in musculoskeletal phenotypes. Polymorphisms in the VDR have been previously associated with several pathologies and muscular strength in athletes and elderly people; however, the literature reported contradictory results. The object of [...] Read more.
The vitamin D receptor (VDR) is an important candidate gene in musculoskeletal phenotypes. Polymorphisms in the VDR have been previously associated with several pathologies and muscular strength in athletes and elderly people; however, the literature reported contradictory results. The object of this research was to verify the association between the most studied VDR variants (rs2228570, rs7975232, and rs1544410) and the increase in muscle mass in elite young soccer players. A sample of 55 soccer players (15–18 years old) from a professional team were selected for this study. DNA was extracted by the salting-out method, and polymorphisms were genotyped by PCR-RFLP, followed by 2% agarose gel electrophoresis. To test the effect of the three SNPs (single nucleotide polymorphisms), a logistic regression analysis was applied. The body composition determination was carried out through the skinfold thickness method, and the muscular area of the arm and lower limb were calculated using the Frisancho formula. All three polymorphisms met the Hardy–Weinberg equilibrium (p > 0.05) and their frequencies fell within the worldwide variability. A significant correlation between rs1544410 and the increase in calf muscle mass was observed. Individuals carrying the A allele showed higher calf muscular mass than those carrying the G allele (p = 0.034). Moreover, a haplotype analysis applied to the two SNPs in linkage disequilibrium (rs7975232 and rs1544410) showed that the AG haplotype appeared negatively correlated to the calf muscle area. In conclusion, we confirm an association between VDR polymorphisms and muscular mass that could encourage the genetic screening of the VDR gene to identify a potential risk of injury and for individual nutritional interventions. Full article
Show Figures

Figure 1

Figure 1
<p>Empirical distribution of PBS values for the <span class="html-italic">VDR</span> gene region. Dashed and horizontal lines represent the 99.5th and 99.9th percentiles, respectively. SNPs under scrutiny are indicated with a square. In the Y axis, PBS values are reported, while in the X axis, the nucleotide positions along the chromosome are indicated.</p>
Full article ">
17 pages, 4413 KiB  
Article
Ameliorative Role of Vitamin C against Cypermethrin Induced Oxidative Stress and DNA Damage in Labeo rohita (Hamilton, 1822) Using Single Cell Gel Electrophoresis
by Sana Ullah, Amina Zuberi, Imdad Ullah and Mahmoud M. Azzam
Toxics 2024, 12(9), 664; https://doi.org/10.3390/toxics12090664 - 12 Sep 2024
Viewed by 377
Abstract
The present study was undertaken to evaluate cypermethrin (CYP)-induced oxidative stress [reactive oxygen species (ROS) and lipid peroxidation (LPO) in gills, muscles, brain, and liver tissues] and DNA damage/genotoxicity (peripheral blood erythrocytes) in a freshwater teleost rohu (Labeo rohita) and the [...] Read more.
The present study was undertaken to evaluate cypermethrin (CYP)-induced oxidative stress [reactive oxygen species (ROS) and lipid peroxidation (LPO) in gills, muscles, brain, and liver tissues] and DNA damage/genotoxicity (peripheral blood erythrocytes) in a freshwater teleost rohu (Labeo rohita) and the protective role of vitamin C. The LC50 of CYP against rohu was found to be 4.5 µg/L in a semi-static culture system through probit analysis. Fingerlings of rohu were distributed into four groups (Group 1st served as a control, fed 35% protein basal diet and was not exposed to CYP; Group 2nd was fed a basal diet and exposed to CYP; Group 3rd and Group 4th were fed diets supplemented with vitamin C at the rate of 100 and 200 mg/kg diet, respectively, and exposed to CYP). Fingerlings were reared on a basal and vitamin C-supplemented diet for 28 days prior to exposure to CYP. The results indicate a time-dependent significant increase in ROS and LPO (indicated by time course increase in TBARS level) as well as DNA damage in terms of number of comets, % DNA in tail, tail moment, tail length, and olive tail moment after exposure to LC50 of CYP. However, statistically comparable results in both Groups 1st and 4th indicate the protective role of vitamin C. The results reveal the effectiveness of vitamin C as a feed additive for countering pesticides toxicity in Labeo rohita. The current study indicates CYP as a potential genotoxicant for fish and classifies SCGE as a reliable and sensitive tool for assessing DNA damage. Full article
(This article belongs to the Special Issue Advances in Chemical Exposure and Environmental Risk)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Reactive oxygen species (ROS) in gills, muscles, brain, and liver tissues of rohu, <span class="html-italic">Labeo rohita</span> (nM DCF/g wet wt.; % of control). Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant difference at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 2
<p>Lipid peroxidation (LPO; μmol/min/mg protein) levels in gills, brain, muscles, and liver tissues of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant difference at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 3
<p>Number of comets per 120 cells observed in peripheral erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant difference at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 4
<p>Length (µm) of comets formed in peripheral blood erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant differences at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 5
<p>Tail length (µm), formed in peripheral erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant differences at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 6
<p>Head length (µm) of comets in peripheral erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant differences at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 7
<p>Percent DNA in tail (%) of comets in peripheral erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant differences at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 8
<p>Tail moment of comets in peripheral erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant difference at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">Figure 9
<p>Olive tail moment of comets in peripheral erythrocytes of rohu, <span class="html-italic">Labeo rohita</span>. Data (presented as mean ± S.E.; N = 9) were analyzed using ANOVA followed by HSK Tukey test. Different symbols on the bars show significant difference at <span class="html-italic">p</span> &lt; 0.05, whereas the same symbol indicates no significant difference.</p>
Full article ">
15 pages, 11104 KiB  
Article
Characterization of Oxacillin-Resistant and Oxacillin-Susceptible mecA-Positive Staphylococcus pseudintermedius from Skin Lesions and Nasal Cavities of Dogs with Clinical Pyoderma
by Putu Ayu Sisyawati Putriningsih, Jaruwan Kampa, Suphattra Jittimanee and Patchara Phuektes
Animals 2024, 14(17), 2613; https://doi.org/10.3390/ani14172613 - 8 Sep 2024
Viewed by 404
Abstract
Understanding the epidemiology of mecA-positive Staphylococcus pseudintermedius strains, including those that are oxacillin-susceptible but potentially inducible to resistance, is crucial for developing effective treatment strategies and mitigating public health risks. This study characterized 87 mecA-positive S. pseudintermedius isolates obtained from skin [...] Read more.
Understanding the epidemiology of mecA-positive Staphylococcus pseudintermedius strains, including those that are oxacillin-susceptible but potentially inducible to resistance, is crucial for developing effective treatment strategies and mitigating public health risks. This study characterized 87 mecA-positive S. pseudintermedius isolates obtained from skin lesions and nasal orifices of 46 dogs with pyoderma enrolled at a referral hospital in Thailand between 2019 and 2020. All isolates underwent antibiogram profiling, SCCmec typing, and pulsed-field gel electrophoresis (PFGE) for phenotypic and genetic analysis. Among the 87 isolates, 33 isolates (37.9%) recovered from 15 dogs were oxacillin-resistant (OR-MRSP), while 54 isolates (62.1%) from 31 dogs were oxacillin-susceptible (OS-MRSP). All OR-MRSP isolates exhibited multidrug resistance (MDR), and 44% of the OS-MRSP isolates also showed MDR. SCCmec typing revealed type V as predominant among OR-MRSP isolates (69.7%), while many oxacillin-susceptible isolates (70.4%) were non-typeable. The OR-MRSP isolates from the same dog showed consistent antibiogram and SCCmec types, while OS-MRSP isolates displayed both identical and diverse patterns. No dominant pulsotypes were observed among the OR-MRSP or OS-MRSP strains. Genetic diversity was also noted among the isolates within the same dogs and among the others, highlighting the complexity of S. pseudintermedius colonization and infection dynamics in pyoderma-affected dogs. Full article
(This article belongs to the Section Companion Animals)
Show Figures

Figure 1

Figure 1
<p>Heat map illustrating the antibiogram patterns of 33 oxacillin-resistant <span class="html-italic">mecA</span>-positive <span class="html-italic">Staphylococcus pseudintermedius</span> (OR-MRSP) isolates. Antimicrobial susceptibility was assessed using the VITEK<sup>®</sup> 2 system. Each row represents an individual isolate, labelled by the dog number from which it was obtained, the sample origin (skin lesion or nasal swab), and the corresponding isolate number from each dog. The heat map employs a color gradient where dark blue boxes indicate resistance, light blue boxes represent intermediate susceptibility, and white boxes represent susceptibility to the tested antibiotics.</p>
Full article ">Figure 2
<p>Heat map illustrating the antibiogram patterns of 54 oxacillin-susceptible <span class="html-italic">mecA</span>-positive <span class="html-italic">Staphylococcus pseudintermedius</span> (OS-MRSP) isolates. Antimicrobial susceptibility was assessed using the VITEK<sup>®</sup> 2 system. Each row represents an individual isolate, labelled by the dog number from which it was obtained, the sample origin (skin lesion or nasal swab), and the corresponding isolate number from each dog. The heat map employs a color gradient where dark blue boxes indicate resistance, light blue boxes represent intermediate susceptibility, and white boxes represent susceptibility to the tested antibiotics.</p>
Full article ">
7 pages, 860 KiB  
Article
Innovative Multiplex PCR Assay for Detection of tlh, trh, and tdh Genes in Vibrio parahaemolyticus with Reference to the U.S. FDA’s Bacteriological Analytical Manual (BAM)
by Seong Bin Park and Yan Zhang
Pathogens 2024, 13(9), 774; https://doi.org/10.3390/pathogens13090774 - 7 Sep 2024
Viewed by 364
Abstract
Vibrio parahaemolyticus is an important foodborne bacterium that causes severe gastroenteritis following the consumption of contaminated seafood. To identify V. parahaemolyticus and determine its pathogenicity, the U.S. Food and Drug Administration (FDA)’s Bacteriological Analytical Manual (BAM) recommends a multiplex polymerase chain [...] Read more.
Vibrio parahaemolyticus is an important foodborne bacterium that causes severe gastroenteritis following the consumption of contaminated seafood. To identify V. parahaemolyticus and determine its pathogenicity, the U.S. Food and Drug Administration (FDA)’s Bacteriological Analytical Manual (BAM) recommends a multiplex polymerase chain reaction (PCR) protocol to simultaneously detect the species-specific thermolabile hemolysin (tlh) gene and the pathogenic thermostable-related hemolysin (trh) and thermostable-direct hemolysin (tdh) genes. However, this assay has shown two limitations: difficulty in separating the amplicons of the trh (486 bp) and tlh (450 bp) genes due to their highly similar sizes, and the weaker band exhibited by the tdh gene amplicon (270 bp). The present study aimed to improve the BAM’s multiplex PCR assay by separating the three amplicons with similar intensity. A new primer set was applied for the tlh gene (369 bp) alongside the existing primers for the trh and tdh genes. The amplicons for the three genes were effectively separated by electrophoresis on a 2% tris-borate-EDTA (TBE) agarose gel within 45 min. Primer concentrations of 0.25 µM for three genes produced a significant amount of amplicons among various combinations of primer concentrations with 35 PCR cycles. This assay exhibited a detection limit of 10 pg of bacterial DNA, demonstrating its high sensitivity. It did not display amplicons from nine Vibrio species known to be human pathogens or from 18 well-documented foodborne pathogens. Therefore, the present multiplex PCR protocol could help overcome the limitations of existing assays and provide a more reliable method for detecting the three genes of V. parahaemolyticus. Full article
Show Figures

Figure 1

Figure 1
<p><b>Multiplex PCR analysis of <span class="html-italic">Vibrio parahaemolyticus tlh</span>, <span class="html-italic">trh,</span> and <span class="html-italic">tdh</span> genes.</b> The protocols were based on the <span class="html-italic">Bacteriological Analytical Manual</span> (<span class="html-italic">BAM</span>) [<a href="#B10-pathogens-13-00774" class="html-bibr">10</a>] of the U.S. FDA and a study by Bej et al. [<a href="#B11-pathogens-13-00774" class="html-bibr">11</a>] (Panel <b>A</b>). (Panel <b>B</b>) showed the current multiplex PCR with various combinations of primers to amplify the middle band of <span class="html-italic">tlh</span> gene (1: 403 bp, 2: 359 bp, and 3: 369 bp). M: Molecular weight marker. The electrophoreses were run for 90 min to separate three bands through a 1.5% TBE agarose gel.</p>
Full article ">Figure 2
<p>Validation of PCR cycle number, sensitivity, and specificity of the current multiplex PCR. (Panel <b>A</b>) The multiplex PCRs were conducted with 30 cycles (Lane 1 and 2) and 35 cycles (Lane 3 to 7) using the protocol of Bej et al. [<a href="#B11-pathogens-13-00774" class="html-bibr">11</a>] (Lane 2 and 3) and the current multiplex PCR (Lane 1, 4, 5, 6, and 7). The sensitivity of the current multiplex PCR was determined using various DNA concentrations (lane 4: 1ng, lane 5: 100 pg, lane 6: 10 pg, and lane 7: 1 pg). (Panel <b>B</b>) Specificity of the current multiplex PCR. <span class="html-italic">Vibrio parahaemolyticus</span> F11-3A exhibited positive results for the <span class="html-italic">trh</span>, <span class="html-italic">tlh</span>, and <span class="html-italic">tdh</span> genes (lane 1). <span class="html-italic">V. parahaemolyticus</span> ATCC 17802 was positive only for the <span class="html-italic">tlh</span> gene (lane 2). <span class="html-italic">V. parahaemolyticus</span> ATCC 35118 showed positivity for the <span class="html-italic">tlh</span> and <span class="html-italic">tdh</span> genes (lane 3). None of the other tested <span class="html-italic">Vibrio</span> strains and foodborne pathogenic bacteria displayed amplification of three genes (lane 4).</p>
Full article ">
12 pages, 3062 KiB  
Article
Aging-Related Metabolome Analysis of the Masseter Muscle in Senescence-Accelerated Mouse-Prone 8
by Yoshiaki Kato, Teruhide Hoshino, Yudai Ogawa, Keisuke Sugahara and Akira Katakura
Int. J. Mol. Sci. 2024, 25(17), 9684; https://doi.org/10.3390/ijms25179684 - 7 Sep 2024
Viewed by 492
Abstract
Frailty is a vulnerable state that marks the transition to long-term care for older people. Early detection and prevention of sarcopenia, the main symptom of frailty, are important to ensure an excellent quality of life for older people. Recently, the relationship between frailty, [...] Read more.
Frailty is a vulnerable state that marks the transition to long-term care for older people. Early detection and prevention of sarcopenia, the main symptom of frailty, are important to ensure an excellent quality of life for older people. Recently, the relationship between frailty, sarcopenia, and oral function has been attracting attention. This study aimed to clarify the changes in metabolites and metabolic pathways due to aging in the masseter muscle of senescence-accelerated mouse-prone 8 (SAMP8) mice. A capillary electrophoresis-mass spectrometry metabolome analysis was performed on the masseter muscle of 12-week-old, 40-week-old, and 55-week-old mice. The expression of enzymes involved in metabolome pathways considered to be related to aging was confirmed using reverse transcription polymerase chain reaction. Clear metabolic fluctuations were observed between 12, 40-week-old, and 55-week-old SAMP8 mice. The extracted metabolic pathways were the glycolysis, polyamine metabolome, and purine metabolome pathways. Nine fluctuated metabolites were common among the groups. Spermidine and Val were increased, which was regarded as a characteristic change in the masseter muscle due to aging. In conclusion, the age-related metabolic pathways in SAMP8 mice were the glycolysis, polyamine metabolome, and purine metabolome pathways. The increased spermidine and Val levels in the masseter muscle compared with the lower limbs are characteristic changes. Full article
(This article belongs to the Special Issue Molecular Research in Skeletal Muscle Metabolism)
Show Figures

Figure 1

Figure 1
<p>Body weights of SAMP8 mice at each age were measured when the masseter muscle was extracted. Body weight at 55 weeks showed a significant increase compared to that at 12 and 40 weeks. *** <span class="html-italic">p</span> &lt; 0.001. <span class="html-italic">X</span>-axis: each age; <span class="html-italic">Y</span>-axis: body weight (g). Plotting points show the weight of each mouse at each stage. The error bars represent the standard deviation.</p>
Full article ">Figure 2
<p>(<b>a</b>) Principal component analysis (PCA) of metabolomic datasets of the masseter muscle (MM) at 12, 40, and 55 weeks. Plots of 12−week−old (blue), 40−week−old (red), and 55−week−old (green) mice are clearly distinguished on the first principal component axis (<span class="html-italic">X</span>−axis). (<b>b</b>) Hierarchical cluster analysis (HCA) of metabolite changes at 12, 40, and 55 weeks. The horizontal axis shows the sample names corresponding to the samples used in <a href="#ijms-25-09684-f002" class="html-fig">Figure 2</a>a (12W−MM1 to 12W−MM4 for 12−week−old mice, 40W−MM1 to 40W−MM4 for 40−week−old mice, and 55W−MM1 to 55W−MM5 for 55−week−old mice). Red indicates that the relative content of metabolites is high, whereas green indicates that the relative content of metabolites is low.</p>
Full article ">Figure 3
<p>Venn diagram of metabolites that fluctuated in all groups. This analysis focused on 116 central metabolites related to central energy metabolic pathways. The fluctuated metabolites common among the groups were Gly, NAD<sup>+</sup>, urea, 2-phosphoglyceric acid, 3-phosphoglyceric acid, phosphoenolpyruvic acid, Val, hydroxyproline, and ATP.</p>
Full article ">Figure 4
<p>Pathway map of polyamine metabolism. Metabolite levels in polyamine metabolism in 40−week−old and 55−week−old mice. ** <span class="html-italic">p</span> &lt; 0.01, * <span class="html-italic">p</span> &lt; 0.05. Gene expressions of involved enzymes are enclosed in the blue squares. <span class="html-italic">X</span>-axis: each age; <span class="html-italic">Y</span>-axis: relative mRNA levels. N.A.: Not Available.</p>
Full article ">Figure 5
<p>Pathway map of purine metabolism. Metabolite levels in purine metabolism in 40−week−old and 55−week−old mice. *** <span class="html-italic">p</span> &lt; 0.001, ** <span class="html-italic">p</span> &lt; 0.01, * <span class="html-italic">p</span> &lt; 0.05. Gene expressions of involved enzymes are enclosed in red squares. <span class="html-italic">X</span>−axis: each age; <span class="html-italic">Y</span>−axis: relative mRNA levels. N.A.: Not Available.</p>
Full article ">Figure 6
<p>Pathway map of glycolysis. Metabolic changes related to polyamine metabolism in 40−week−old and 55−week−old mice. *** <span class="html-italic">p</span> &lt; 0.001, ** <span class="html-italic">p</span> &lt; 0.01. N.A.: Not Available.</p>
Full article ">
11 pages, 4753 KiB  
Article
Development and Characterization of a New TILLING Population for Forward and Reverse Genetics in Barley (Hordeum vulgare L.)
by Feifei Wang, Liang Zhu, Zhenxiang Zhou, Yangyang Gu, Baojian Guo, Chao Lv, Juan Zhu, Xiaohui Liu and Rugen Xu
Plants 2024, 13(17), 2490; https://doi.org/10.3390/plants13172490 - 5 Sep 2024
Viewed by 323
Abstract
Mutagenesis is an important tool in crop improvement and free of the regulatory restrictions imposed on genetically modified organisms. Barley (Hordeum vulgare L.) is a diploid species with a genome smaller than those of other members of the Triticeae crops, making it [...] Read more.
Mutagenesis is an important tool in crop improvement and free of the regulatory restrictions imposed on genetically modified organisms. Barley (Hordeum vulgare L.) is a diploid species with a genome smaller than those of other members of the Triticeae crops, making it an attractive model for genetic studies in Triticeae crops. In this study, we report an ethyl methane sulfonate (EMS)-mutagenized population in the Chinese barley landrace TX9425, which is tolerant to both abiotic and biotic stress. A TILLING (Targeting Induced Locus Lesion in Genomes) population consisting of 2000 M2 lines was also constructed based on the CEL I enzyme with subsequent polyacrylamide electrophoresis, which decreased the cost and labor investment. The mutant phenotypes of the M2 and M3 generations were scored and revealed the presence of a wide spectrum of morphological diversity. The population was evaluated by screening for induced mutations in five genes of interest. A detailed analysis was performed for the HvGLR3.5 gene and three mutations were identified by screening in 2000 M2 lines. Two of three mutations displayed tuft and yellow striped leaves compared to the wild type. Altogether, our study shows the efficiency of screening and the great potential of the new TILLING population for genetic studies in the barley crop model system. Full article
(This article belongs to the Special Issue The Genetic Improvement of Barley)
Show Figures

Figure 1

Figure 1
<p>The phenotype of TX9425 (TX). TX is a Chinese two-rowed and hulled barley variety, which is mainly used for feeding. The image of the left panel (<b>A</b>) shows the whole plant after the filling period, and the top right image (<b>B</b>) shows the whole spike and seeds with awns. The bottom right image (<b>C</b>) shows the mature seeds. The thousand-kernel weight (<b>D</b>), relative water content (<b>E</b>), nitrogen content (<b>F</b>), and crude protein content (<b>G</b>) of TX and NasoNijo. NasoNijo (NN) is a Japanese two-rowed and hulled barley variety, which is mainly used for malting.</p>
Full article ">Figure 2
<p>The phenotypes of M<sub>3</sub> mutants in the field: (<b>A</b>) thin leaf, (<b>B</b>) leaf yellow stripes, (<b>C</b>) leaf tip yellow, (<b>D</b>) non-tillering, (<b>E</b>) multi-noded, (<b>F</b>) wild type of whole plant, (<b>G</b>) short awn, (<b>H</b>) awnless, (<b>I</b>) spike anomaly, (<b>J</b>) white glume, (<b>K</b>) red glume, (<b>L</b>) wild type of spike.</p>
Full article ">Figure 3
<p><span class="html-italic">Hvglr3.5</span> mutants detected from the TILLING population. The mutation locations (red main string) were shown in <span class="html-italic">HvGLR3.5</span> gene structure and all the mutations were synonymously (<b>A</b>). Two homozygous M<sub>3</sub> plants, FM10587 and FM10811, were detected from the TILLING population. The chlorophyll relative content (SPAD), root length, and plant height of two mutants and TX were measured at the seedling stage (<b>B</b>). Single seedling in the pot ((<b>C</b>): FM10587; (<b>D</b>): FM10811; (<b>E</b>): TX) and seedling images in the field are shown ((<b>F</b>): FM10587; (<b>G</b>) left: FM10811; (<b>G</b>) right: TX). * indicates significant difference (<span class="html-italic">p</span> &lt; 0.05), ** indicates significant difference (<span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">
12 pages, 1120 KiB  
Article
Body Height of MPS I and II Patients after Hematopoietic Stem Cell Transplantation: The Impact of Dermatan Sulphate
by Patryk Lipiński, Agnieszka Różdżyńska-Świątkowska, Agnieszka Ługowska, Jolanta Marucha, Katarzyna Drabko and Anna Tylki-Szymańska
Diagnostics 2024, 14(17), 1956; https://doi.org/10.3390/diagnostics14171956 - 4 Sep 2024
Viewed by 274
Abstract
Introduction: Hematopoietic stem cell transplantation (HSCT) comprises one of the two main treatment regimens for patients with mucopolysaccharidoses (MPS). There is a scarcity of literature concerning the process of growth in children with Mucopolysaccharidosis type I (MPS I) and Mucopolysaccharidosis type I (MPS [...] Read more.
Introduction: Hematopoietic stem cell transplantation (HSCT) comprises one of the two main treatment regimens for patients with mucopolysaccharidoses (MPS). There is a scarcity of literature concerning the process of growth in children with Mucopolysaccharidosis type I (MPS I) and Mucopolysaccharidosis type I (MPS II) after HSCT. The aim of this manuscript was to evaluate the therapeutic effect of HSCT on the heights of patients with MPS I and MPS II. Material and methods: It was an observational, single-center study on patients with MPS I and II treated with HSCT. Results: 6 MPS patients, including 4 MPS I and 2 MPS II, underwent HSCT at a median age of 2 years. All patients are alive to date, with a median age of 7.7 years (range 5.5–12 years) at the last follow-up. In both (MPS I and MPS II) groups of patients treated with HSCT, the growth rate was higher than in untreated patients and was found to be in line with the population norm. In both MPS I and MPS II patients who were treated with HSCT, normalization of urinary GAG excretion was observed. Additionally, no bands of DS and HS in GAG electrophoresis were visible. Conclusions: Both MPS I and MPS II patients presented height gain after HSCT compared to the curves of untreated patients. The absence of dermatan sulphate after HSCT could lead to normal growth in bone length. Full article
(This article belongs to the Special Issue Diagnosis and Management of Metabolic Bone Diseases: 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Body height of MPS I patients after HSCT (red lines; arrow—time of HSCT) with comparison with untreated patients (blue line).</p>
Full article ">Figure 2
<p>Body height of MPS II patients after HSCT (red lines; arrow—time of HSCT) with comparison with untreated patients (blue line).</p>
Full article ">Figure 3
<p>Changes in GAG electrophoresis in MPS I patients after HSCT and ERT. Abbreviations: SCh—chondroitin sulphate; SD—dermatan sulphate; SH—heparan sulphate; GAG—glycosaminoglycan; ERT—enzyme replacement therapy; HSCT—hematopoietic stem cell transplantation. (<b>A</b>) 1—before treatment; 2—after 2 years of HSCT; 3—after 4 years of HSCT. (<b>B</b>) 1—before treatment; 2—after 2 years of HSCT; 3—after 3 years of HSCT. (<b>C</b>) 1—before treatment; 2—control sample; 3—after 11 years of ERT; 4—after 21 years of ERT. (<b>D</b>) 1—control sample; 2—before treatment; 3—after 11 years of ERT; 4—after 21 years of ERT.</p>
Full article ">Figure 4
<p>Changes in GAG electrophoresis in MPS II patients after HSCT and ERT. Abbreviations: SCh—chondroitin sulphate; SD—dermatan sulphate; SH—heparan sulphate; GAG—glycosaminoglycan; ERT—enzyme replacement therapy; HSCT—hematopoietic stem cell transplantation. (<b>A</b>) 1—before treatment; 2—after 9 months of HSCT. (<b>B</b>) 1—before treatment; 2—after 3 years of HSCT; 3—after 3 years and 4 months of HSCT. (<b>C</b>) 1—before treatment; 2—after 7.5 years of ERT; 3—after. 2.5 years of ERT; 4—after 16 years of ERT; 5—after 21 years of ERT. (<b>D</b>) 1—before treatment; 2—after 1.5 years of ERT; 3—after 3 years of ERT; 4—after 4.5 years of ERT. (<b>E</b>) 1—before treatment; 2—after 6 years of HSCT; 3—after 10 years of HSCT. (<b>F</b>) 1—MPS II without treatment.</p>
Full article ">
12 pages, 2919 KiB  
Article
Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma
by Stefan Lozenov, Yoanna Tsoneva, Georgi Nikolaev and Rossitza Konakchieva
Diagnostics 2024, 14(17), 1953; https://doi.org/10.3390/diagnostics14171953 - 3 Sep 2024
Viewed by 367
Abstract
The Ikaros zinc finger factor 1 is a transcription factor with a well-known role in B- and T-cell development. The deletions of IKZF1 have an established significance in acute lymphoblastic leukemia, while reports on its prevalence and prognostic significance among ALL subtypes and [...] Read more.
The Ikaros zinc finger factor 1 is a transcription factor with a well-known role in B- and T-cell development. The deletions of IKZF1 have an established significance in acute lymphoblastic leukemia, while reports on its prevalence and prognostic significance among ALL subtypes and regions vary. Breakpoint-specific qPCR is a practical method for testing of the most frequent types of IKZF1 deletions, considering there is clustering of the deletion events. The most commonly reported deletions are Δ4–7, Δ4–8, Δ2–7, and Δ2–8, with deletion Δ4–7 being the most common one. We retrospectively administered a breakpoint-specific qPCR design for screening for the most frequent types of IKZF1 deletions to 78 ALL patients that were diagnosed and treated between 2010 and 2022. We observed the products through gel electrophoresis, and we conducted descriptive statistics, EFS, and OS analyses. Our study found 19 patients with IKZF1 deletions, with two subjects manifesting more than one deletion. The prevalence in the different subgroups was as follows: Ph/+/ B-ALL 46%, Ph/−/ B-ALL 30%, T-ALL/LBL 4%. There was a statistically significant difference in EFS of 39 vs. 0% in favor of patients without deletions (p = 0.000), which translated to a difference in OS of 49 vs. 0% (p = 0.001). This difference was preserved in the subgroup of Ph/−/ B-ALL, while there was no significant difference in the Ph/+/ B-ALL. The most frequently observed type of deletion (15 out of 19) was the Δ4–7. There is a strong negative prognostic impact of the IKZF1 deletions at diagnosis in the observed population. IKZF1 deletion testing through breakpoint-specific qPCR is a practical approach in diagnostic testing for this risk factor. IKZF1 deletions may warrant treatment decisions and intensified treatment strategies to overcome the negative prognostic impact. Full article
(This article belongs to the Special Issue Diagnosis, Prognosis and Management of Hematologic Malignancies)
Show Figures

Figure 1

Figure 1
<p>Structure of the <span class="html-italic">IKZF1</span> gene with the location of breakpoint clusters and primer locations.</p>
Full article ">Figure 2
<p>(<b>A</b>,<b>B</b>) Gel electrophoresis. (<b>A</b>) deletion of Δ2–7 and Δ4–7. (<b>B</b>) deletion of Δ4–7.</p>
Full article ">Figure 2 Cont.
<p>(<b>A</b>,<b>B</b>) Gel electrophoresis. (<b>A</b>) deletion of Δ2–7 and Δ4–7. (<b>B</b>) deletion of Δ4–7.</p>
Full article ">Figure 3
<p>EFS for deleted <span class="html-italic">IKZF1</span> versus non-deleted <span class="html-italic">IKZF1</span> without censoring for HSCT.</p>
Full article ">Figure 4
<p>OS for deleted <span class="html-italic">IKZF1</span> versus non-deleted <span class="html-italic">IKZF1</span> without censoring for HSCT.</p>
Full article ">Figure 5
<p>Cumulative incidence of relapse with death as competing factor deleted <span class="html-italic">IKZF1</span> vs. non-deleted <span class="html-italic">IKZF1</span>.</p>
Full article ">
16 pages, 5478 KiB  
Protocol
Simultaneous Visualization of R-Loops/RNA:DNA Hybrids and Replication Forks in a DNA Combing Assay
by Miroslav Penchev Ivanov, Heather Zecchini and Petra Hamerlik
Genes 2024, 15(9), 1161; https://doi.org/10.3390/genes15091161 - 3 Sep 2024
Viewed by 935
Abstract
R-loops, structures that play a crucial role in various biological processes, are integral to gene expression, the maintenance of genome stability, and the formation of epigenomic signatures. When these R-loops are deregulated, they can contribute to the development of serious health conditions, including [...] Read more.
R-loops, structures that play a crucial role in various biological processes, are integral to gene expression, the maintenance of genome stability, and the formation of epigenomic signatures. When these R-loops are deregulated, they can contribute to the development of serious health conditions, including cancer and neurodegenerative diseases. The detection of R-loops is a complex process that involves several approaches. These include S9.6 antibody- or RNAse H-based immunoprecipitation, non-denaturing bisulfite footprinting, gel electrophoresis, and electron microscopy. Each of these methods offers unique insights into the nature and behavior of R-loops. In our study, we introduce a novel protocol that has been developed based on a single-molecule DNA combing assay. This innovative approach allows for the direct and simultaneous visualization of RNA:DNA hybrids and replication forks, providing a more comprehensive understanding of these structures. Our findings confirm the transcriptional origin of the hybrids, adding to the body of knowledge about their formation. Furthermore, we demonstrate that these hybrids have an inhibitory effect on the progression of replication forks, highlighting their potential impact on DNA replication and cellular function. Full article
(This article belongs to the Special Issue DNA Damage Repair in Cancers)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Simultaneous visualization of replication forks and RNA:DNA hybrids in a DNA combing assay. (<b>A</b>) Example fields of view of combed DNA, stained for single-stranded DNA (green), RNA:DNA hybrids/R-loops (red), and replication forks: CldU (cyan), followed by IdU (yellow). RNA:DNA hybrids and replication forks can appear independently or colocalize. (<b>B</b>) Zoomed-in examples of co-staining of RNA:DNA hybrids and replication forks in combed DNA. The dashed hybrid staining indicates that the structures are beyond the resolution limit. Asterisk: one of the larger intact hybrids observed with a length of about 3.5 kb. (<b>C</b>) Effect of transcription inhibition with actinomycin D on RNA:DNA hybrid abundance. 10 μM Actinomycin D was added to cells for 1 h prior to as well as during cell labelling. The number of hybrid spots normalized to DNA or Background area in a technical triplicate are plotted as Mean +/− SD. Statistical difference between non-treated (−) and actinomycin D-treated (+) cells is calculated by one-way ANOVA, (∗∗) adjusted <span class="html-italic">p</span>-value = 0.0054. Hybrids are identified exclusively in the DNA area and their abundance is reduced upon transcriptional inhibition. Background = non-DNA area. (<b>D</b>) Breakdown of technical triplicates in (<b>C</b>) by repeat and S9.6 antibody source.</p>
Full article ">Figure 2
<p>Direct measurement of the inhibitory effect of RNA:DNA hybrid/R-loop collisions on replication fork progression. (<b>A</b>) Two examples of sister forks of different lengths correlated with RNA:DNA hybrid/R-loop colocalization. Left: The left fork, which interferes with more hybrids, is shorter than its sister, which interferes with fewer hybrids. Right: The left fork, which interferes with hybrids is shorter than its sister, which is unchallenged by hybrids. The brightness and contrast of the entire image are adjusted in Photoshop. (<b>B</b>) An example of a replication fork collapse at a cluster of RNA:DNA hybrids/R-loops. The left sister fork collapses at a stretch of hybrids while the right sister fork progresses unimpeded. The brightness and contrast of the entire image are adjusted in Photoshop. (<b>C</b>) Frequency distribution of replication fork lengths (IdU) in DU145 Wild type grouped based on colocalization with at least one hybrid dot (black) or free of hybrids (grey). Manual measurement with FIJI. Gaussian fitting for visualization purposes. (<b>D</b>) Frequency distribution of replication fork lengths (IdU) in DU145 BRCA1 knockout grouped based on colocalization with at least one hybrid dot (black) or free of hybrids (grey). Manual measurement with FIJI. Gaussian fitting for visualization purposes. (<b>E</b>) Frequency distribution of replication fork lengths (IdU) in DU145 ATM knockout grouped based on colocalization with at least one hybrid dot (black) or free of hybrids (grey). Manual measurement with FIJI. Gaussian fitting for visualization purposes. (<b>F</b>) Violin plot visualisation of the data from (<b>C</b>), based on 586 manually measured forks (201 with hybrids, median = 11.87 AU; 385 without hybrids, median = 14.54 AU). Mann Whitney test—Significant, <span class="html-italic">p</span> value &lt; 0.0001 (∗∗∗∗). (<b>G</b>) Violin plot visualisation of the data from (<b>D</b>), based on 544 manually measured forks (165 with hybrids, median = 13.07 AU; 379 without hybrids, median = 15.74 AU). Mann Whitney test—Significant, <span class="html-italic">p</span> value &lt; 0.0001 (∗∗∗∗). (<b>H</b>) Violin plot visualisation of the data from (E), based on 569 manually measured forks (224 with hybrids, median = 11.21 AU; 345 without hybrids, median = 14.54 AU). Mann Whitney test—Significant, <span class="html-italic">p</span> value &lt; 0.0001 (∗∗∗∗). (<b>I</b>) Ratios between lengths of sister forks, pooled from the three cell lines analysed in (<b>C</b>–<b>E</b>). Only pairs in which one fork colocalizes with hybrid(s) and its sister is free of hybrids are analysed. The median ratio between sisters with hybrids and without hybrids is 0.87. Based on 73 sister pairs. Forks with hybrids tend to be shorter than their sisters without hybrids within similar chromatin context.</p>
Full article ">
12 pages, 1620 KiB  
Article
Comparison of Likelihood Ratios from Probabilistic Genotyping for Two-Person Mixtures across Different Assays and Instruments
by Dennis McNevin and Mark Barash
Forensic Sci. 2024, 4(3), 441-452; https://doi.org/10.3390/forensicsci4030028 - 2 Sep 2024
Viewed by 347
Abstract
Continuous probabilistic genotyping (PG) provides a means to estimate the probative value of DNA mixtures tendered as evidence in court and subject to alternative propositions about the contributors to the mixtures. The weight of that evidence, however, may be valued differently, depending on [...] Read more.
Continuous probabilistic genotyping (PG) provides a means to estimate the probative value of DNA mixtures tendered as evidence in court and subject to alternative propositions about the contributors to the mixtures. The weight of that evidence, however, may be valued differently, depending on which forensic laboratory undertook the DNA analysis. There is a need, therefore, to have a means for the comparison of likelihood ratios (LRs) generated by continuous PG amongst different laboratories for the same initial DNA sample. Such a comparison would enable the courts and the public to make judgements about the reliability of this type of evidence. There are particular mixtures and methods for which such a comparison is meaningful, and this study explores them for the short tandem repeat (STR) electropherograms of two-person mixtures obtained from the PROVEDIt Database. We demonstrate a common maximum attainable LR for a given set of common STR loci and a given DNA mixture that is consistent across three different STR profiling assays and two different capillary electrophoresis instruments. Full article
Show Figures

Figure 1

Figure 1
<p>LRs calculated for proposition pairs 1 (<b>top</b>), 2 (<b>middle</b>), and 3 (<b>bottom</b>). STR profiling assays are <span style="color:red">Identifiler™ Plus</span>, <span style="color:#00B0F0">GlobalFiler™</span> and <span style="color:#00B050">Fusion 6C</span>. CE injection times are 5 s (<tt>○</tt>), 10–15 s (□) and 20–25 s (◊).</p>
Full article ">Figure 2
<p>LRs calculated for proposition pairs 1 (<b>top</b>), 2 (<b>middle</b>), and 3 (<b>bottom</b>). STR profiling assays are <span style="color:red">Identifiler™ Plus</span>, <span style="color:#00B0F0">GlobalFiler™</span> and <span style="color:#00B050">Fusion 6C</span>.</p>
Full article ">Figure 3
<p>Electropherograms (CXR dye) for the three CE injections of 0.0625 ng DNA template amounts amplified by PowerPlex<sup>®</sup> Fusion 6C System. CE injection times are 5 s (<b>top</b>), 15 s (<b>middle</b>), and 25 s (<b>bottom</b>). D8S1179 is the first locus at the left in all three epgs.</p>
Full article ">Figure 4
<p>Detail from epgs at D5S818 derived from amplification of 0.125 ng DNA with various CE injection times showing dropout of allele 12 for GlobalFiler™ and PowerPlex<sup>®</sup> Fusion 6C but not for Identifiler™ Plus.</p>
Full article ">
16 pages, 4720 KiB  
Article
Stage-Specific Plasma Metabolomic Profiles in Colorectal Cancer
by Tetsuo Ishizaki, Masahiro Sugimoto, Yu Kuboyama, Junichi Mazaki, Kenta Kasahara, Tomoya Tago, Ryutaro Udo, Kenichi Iwasaki, Yutaka Hayashi and Yuichi Nagakawa
J. Clin. Med. 2024, 13(17), 5202; https://doi.org/10.3390/jcm13175202 - 2 Sep 2024
Viewed by 359
Abstract
Background/Objectives: The objective of this study was to investigate the metabolomic profiles of patients with colorectal cancer (CRC) across various stages of the disease. Methods: The plasma samples were obtained from 255 subjects, including patients with CRC in stages I-IV, polyps, [...] Read more.
Background/Objectives: The objective of this study was to investigate the metabolomic profiles of patients with colorectal cancer (CRC) across various stages of the disease. Methods: The plasma samples were obtained from 255 subjects, including patients with CRC in stages I-IV, polyps, and controls. We employed capillary electrophoresis time-of-flight mass spectrometry and liquid chromatography triple quadrupole mass spectrometry to analyze hydrophilic metabolites comprehensively. The data were randomly divided into two groups, and consistent differences observed in both groups were analyzed. Results: Acetylated polyamines, such as N1-acetylspermine and N1, N12-diacetylspermine, consistently showed elevated concentrations in stage IV compared to stages I-III. Non-acetylated polyamines, including spermine and spermidine, exhibited increasing trends from polyp to stage IV. Other metabolites, such as histidine and o-acetylcarnitine, showed decreasing trends across stages. While acetylated polyamines have been reported as CRC detection markers, our findings suggest that they also possess diagnostic potential for distinguishing stage IV from other stages. Conclusions: This study showed stage-specific changes in metabolic profiles, including polyamines, of colorectal cancer. Full article
Show Figures

Figure 1

Figure 1
<p>Volcano plots for the comparison of metabolome profiles between stages I–III and stage IV. (<b>A</b>) Training data. (<b>B</b>) Validation data. The X-axis represents log<sub>2</sub>-fold change (stage IV/stages I–III), and the Y-axis shows the −log<sub>10</sub>(<span class="html-italic">p</span>) values for each metabolite. The <span class="html-italic">p</span>-values were calculated using the Mann–Whitney U test. The horizontal line indicates −log<sub>10</sub>(<span class="html-italic">p</span>) = 1.3, and the metabolites above this line indicate significant differences (<span class="html-italic">p</span> &lt; 0.05). Metabolites with log<sub>10</sub>(<span class="html-italic">p</span>) ≥ 1.3 are color-coded in red (higher in stage IV) or blue (higher in stages I–III).</p>
Full article ">Figure 2
<p>Box plots of acetylated polyamines, including <span class="html-italic">N</span><sup>1</sup>,<span class="html-italic">N</span><sup>12</sup>-diacetylspermine and <span class="html-italic">N</span><sup>1</sup>-acetylspermidine. (<b>A</b>,<b>B</b>) Absolute concentration without normalization. (<b>C</b>,<b>D</b>) Relative concentration with normalization. (<b>A</b>,<b>C</b>) Training data. (<b>B</b>,<b>D</b>) Validation data. Horizontal bars of box plots indicate data of 100, 75, 50, 25, and 0%. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 (Mann–Whitney test).</p>
Full article ">Figure 3
<p>Metabolite with an increasing or decreasing trend with progress. PatternHunter function of MetaboAnalyst with Spearman correlation option is used. (<b>A</b>) Training data. (<b>B</b>) Validation data. Metabolites with positive–negative correlations are colored pink and light blue, respectively, and they ranked high in both datasets. The box plots of these metabolites are shown.</p>
Full article ">Figure 4
<p>Heat map to show metabolite concentrations. Metabolites showing high variance (top 25 by ANOVA) are shown. Log<sub>10</sub>-transformed absolute concentration is clustered by Euclidean distance with Ward clustering methods. The metabolites with increasing and decreasing trends with progress found in <a href="#jcm-13-05202-f003" class="html-fig">Figure 3</a> are colored.</p>
Full article ">Figure 5
<p>Pathway-level differences between stages I–III and stage IV. (<b>A</b>,<b>B</b>) Enrichment Analysis. The X-axis and colors represent the enrichment ratio and <span class="html-italic">p</span>-value for each pathway, respectively. (<b>C</b>,<b>D</b>) Pathway analysis. Both analyses use KEGGs Pathways. (<b>A</b>,<b>C</b>) Training data. (<b>B</b>,<b>D</b>) Validation data. The X- and Y-axes represent the impact score and −log<sub>10</sub>(<span class="html-italic">p</span>) for each pathway, respectively.</p>
Full article ">Figure A1
<p>Volcano plots for comparing metabolome profiles between stages I–III and stage IV. (<b>A</b>,<b>C</b>) Training data. (<b>B</b>,<b>D</b>) Validation data. The X-axis represents log<sub>2</sub>-fold change (stage IV/stages I–III), and the Y-axis shows −log10(<span class="html-italic">p</span>) values of each metabolite. The <span class="html-italic">p</span>-values were calculated using the Mann–Whitney U test. The horizontal line indicates −log<sub>10</sub>(<span class="html-italic">p</span>) = 1.3, and the metabolites above this line indicate significant differences (<span class="html-italic">p</span> &lt; 0.05). Metabolites with log<sub>10</sub>(<span class="html-italic">p</span>) ≥ 1.3 are color-coded in red (higher in stage IV) or blue (higher in stages I–III). (<b>A</b>,<b>B</b>) Metabolite concentrations processed with quantile normalization are used. (<b>C</b>,<b>D</b>) <span class="html-italic">p</span>-values are corrected by a false discovery rate.</p>
Full article ">Figure A2
<p>Receiver operating characteristic (ROC) curves for metabolites distinguishing stage IV data from stages I–III data. The area under the ROC curve, 95% confidence interval, and <span class="html-italic">p</span>-value are shown. (<b>A</b>,<b>B</b>) Absolute concentration without normalization. (<b>C</b>,<b>D</b>) Relative concentration with normalization. (<b>A</b>,<b>C</b>) Training data. (<b>B</b>,<b>D</b>) Validation data.</p>
Full article ">Figure A3
<p>Receiver operating characteristic (ROC) curves for tumor makers distinguishing stage IV data from stages I–III data. The area under the ROC curve, 95% confidence interval, and <span class="html-italic">p</span>-value are shown. (<b>A</b>,<b>B</b>) CEA. (<b>C</b>,<b>D</b>) CA19-9. (<b>A</b>,<b>C</b>) Training data. (<b>B</b>,<b>D</b>) Validation data. Missing data are as follows: (<b>A</b>) stages I–III (n = 1) and stage IV (n = 1), (<b>B</b>) no, (<b>C</b>) stages I–III (n = 1) and stage IV (n = 1), and (<b>D</b>) stages I–III (n = 3).</p>
Full article ">Figure A4
<p>Sex-dependent differences in box plots of acetylated polyamines, including <span class="html-italic">N</span><sup>1</sup>,<span class="html-italic">N</span><sup>12</sup>-diacetylspermine, <span class="html-italic">N</span><sup>1</sup>-acetylspermidine, and histidine (His). Absolute concentrations without normalization are used. Horizontal bars of box plots indicate the data of 100, 75, 50, 25, and 0%. <span class="html-italic">p</span> &lt; 0.05 (Mann–Whitney test).</p>
Full article ">Figure A5
<p>Age-dependent differences in box plots of acetylated polyamines, including <span class="html-italic">N</span><sup>1</sup>,<span class="html-italic">N</span><sup>12</sup>-diacetylspermine, <span class="html-italic">N</span><sup>1</sup>-acetylspermidine, and histidine (His). The data were compared by splitting the data≥ and &lt;the median age of 69.5. Absolute concentrations without normalization are used. Horizontal bars of box plots indicate the data of 100, 75, 50, 25, and 0%. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, and *** <span class="html-italic">p</span> &lt; 0.001 (Mann–Whitney test).</p>
Full article ">
Back to TopTop